Delivery Order SPE2DR25D3016-SPE2DR26FG3VB
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,088.63 to Amerisourcebergen Drug Corp (parent company Cencora, Inc.) on January 27, 2026, for M-M-R II vaccine vials, with a completion deadline of January 28, 2026. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. The award represents a task order under Amerisourcebergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $3,034.01 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on December 19, 2025, with an ultimate completion date of December 22, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value transaction supporting federal medical supply needs. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a $3,177.90 delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on January 15, 2026, with completion scheduled for January 16, 2026. This is a firm fixed-price contract with no set-aside designation, performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order represents a task order issued under AmerisourceBergen's parent company, Cencora, Inc.'s larger Indefinite Delivery Contract with the DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,729.69 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of January 15, 2026. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, which serves as the corporate headquarters for the awardee. This delivery order represents a task order issued...
- The Defense Logistics Agency awarded a $9,963.87 delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on January 8, 2026, with completion scheduled for January 9, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,259.06 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of January 22, 2026. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor's corporate office located in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,326.27 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on January 28, 2026, with completion scheduled for January 29, 2026. This competitively awarded, non-set-aside contract utilizes firm fixed-price pricing and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical...
- The Defense Logistics Agency awarded a $31,839.65 delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on January 7, 2026, with a completion date of January 8, 2026. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving critical federal medical...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., received a $4,375.38 firm fixed-price delivery order from the Defense Logistics Agency (DLA) on January 7, 2026, for M-M-R II vaccine vials. The contract is a non-set-aside award with an ultimate completion date of January 8, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under a larger Indefinite Delivery Contract with DLA Troop Support Medical valued at...
- The Defense Logistics Agency awarded a delivery order valued at $3,835.09 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with a completion date of December 23, 2025. This contract employs firm fixed pricing and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare...
- SPE2DR25D3016Indefinite Delivery Contract
- SPE2DR25D3016-SPE2DR26FG3VBDelivery Order
The Defense Logistics Agency awarded a $3,532.74 firm fixed-price delivery order to Amerisourcebergen Drug Corp (parent company Cencora, Inc.) on January 27, 2026, for M-M-R II vaccine vials. This is a non-set-aside competitive award with an ultimate completion date of January 28, 2026. The contract represents a task order under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2026. This prime contract vehicle provides comprehensive pharmaceutical and medical supply support to military healthcare programs globally, enabling the delivery of vaccines, specialty medications, brand-name and generic drugs, and related medical commodities across multiple therapeutic domains. Amerisourcebergen Drug Corp, headquartered in Conshohocken, Pennsylvania—which is also the place of performance for this order—is a major pharmaceutical distributor and critical federal vendor serving military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill competitive procurement requirements for medical products. Performance will be completed from the company's corporate office location in Pennsylvania, supporting the Defense Logistics Agency's mission to supply essential vaccines and medical products to the Department of Defense health system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 1/26/26 |